Cleland, J.G.F.

patient heart failure heart failure advice treatment trial study mortality survey disease hospital euroheart failure survey effect point group function analysis eur j heart cardiology european diagnosis outcome euroheart end points event therapy result inhibitor / european journal swedberg k hospitalization dysfunction department spironolactone target management cleland table systolic dysfunction cardiol atrial morbidity discharge value country heart failure patients systolic blocker end point infarction university condition death beta-blocker ace inhibitors number intervention score measure swedberg eu countries characteristic vessel vessel size lifestyle advice .001 medicine change follow-up society interview intake guideline ef ficacy all-cause mortality platelet quality lesion difference